Commercialize Your MedTech with Craig T Ingram | Ep. 15

The Med Device Cyber Podcast · with Craig · May 1, 2025 This episode of The Med Device Cyber Podcast features Craig T. Ingram, an expert with 27 years in MedTech, discussing the critical yet often overlooked aspects of commercialization in the medical device industry. He highlights how many startups and small to medium-sized enterprises fail due to low customer adoption, attributing this to a lack of a cohesive commercialization roadmap rather than just sales or marketing plans. Ingram emphasizes the multifaceted nature of commercialization, involving ten key components, including regulatory affairs, product design, and alliances. The conversation pivots to the crucial role of cybersecurity, not as an "evil" expense, but as a critical form of insurance against malicious activity and data breaches. The discussion underscores that cybersecurity is intrinsically linked to regulatory compliance, such as HIPAA and FDA requirements, and is essential for preventing patient harm. Ingram also critiques the "move fast and break things" mindset prevalent in some startups, advocating for wisdom and thoroughness over haste. The episode provides valuable insights for product security teams, regulatory leads, and engineers on integrating cybersecurity and smart commercialization strategies from the outset to ensure product success and patient safety.

Key Takeaways

• Many MedTech startups and small to medium-sized enterprises fail due to low customer adoption, often because they lack a comprehensive commercialization roadmap that integrates crucial components beyond just sales and marketing.
• Cybersecurity in MedTech should be viewed as critical insurance and a necessary component of regulatory compliance, rather than just an expense, to prevent malicious activity and protect sensitive data and patient well-being.
• Regulatory affairs, specifically mentioned as the third component of commercialization, directly incorporates cybersecurity as a requirement for compliance with regulations like HIPAA and FDA mandates, ensuring product safety and market approval.
• The "move fast and break things" startup mentality can lead to significant challenges and ineffectiveness in commercialization; wisdom and thoroughness are more vital for sustainable success in the MedTech industry.
• Effective commercialization requires understanding that value is not about the cheapest or most expensive solution, but obtaining the best output and addressing specific needs, particularly in cybersecurity where specialized MedTech expertise is crucial for FDA compliance.
• Patient harm, rather than just data breaches, should be the primary concern when considering medical device cybersecurity, as highlighted by the potential for malicious attacks to directly impact the functionality of devices like surgical robots or diagnostic tools.

Listen on mdcpodcast.com · Watch on YouTube

Listen to this episode

• Watch on YouTube
• Listen on Apple Podcasts
• Listen on Spotify
• Browse all episodes

---

Want help applying this to your own device program?

Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.